SecurLinx Corporation – Trademark Portfolio
Entity Type: 03
SecurLinx Corporation holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include IDTRAC, THINAIR, FACETRAC, VERITRAC, and SECURLINX. The owner is based in Morgantown, WV.
150 Clay Street, Suite 440
Morgantown, WV 26501
Showing of trademarks Trademarks
Trademark Classifications
SecurLinx Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SecurLinx Corporation have?
SecurLinx Corporation has 19 U.S. trademarks filed with the USPTO. Of these, 8 registered, 9 abandoned, 2 cancelled.
What trademark classes does SecurLinx Corporation file in?
SecurLinx Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are SecurLinx Corporation's most well-known trademarks?
SecurLinx Corporation's registered trademark portfolio includes well-known marks such as IDTRAC, THINAIR, FACETRAC, VERITRAC, and SECURLINX. These are among 8 currently registered trademarks in the portfolio.
What is SecurLinx Corporation's trademark registration success rate?
SecurLinx Corporation has a 42% trademark registration rate, with 8 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.